Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)

Clinical trial NCT06488118 · UNKNOWN

Trial details

NCT number: NCT06488118
Sponsor: Akhilesh Jha
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Innate Immunity Mucosal Immunity Asthma Viral Infection

Start date: 2024-05-24
Primary completion: 2025-05-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.